Clinical and research tests for C2751318 - Genetic Testing Registry (GTR) - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

<< First < Prev

Page 2 of 3

Results: 21 to 40 of 53

Tests names and labs	Conditions	Genes, analytes, and microbes	Methods
CancerNext® Ambry Genetics United States	80	34	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Hereditary Breast and Ovarian Cancer - Expanded and Lynch Syndrome Panel PreventionGenetics, part of Exact Sciences United States	29	33	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Hereditary Ovarian Cancer Panel PreventionGenetics, part of Exact Sciences United States	40	30	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
VistaSeq Breast Cancer Panel Molecular Diagnostic Laboratory LabCorp United States	16	19	D Deletion/duplication analysis C Sequence analysis of the entire coding region
VisaSeq Breast and GYN Cancer Panel Molecular Diagnostic Laboratory LabCorp United States	32	25	D Deletion/duplication analysis C Sequence analysis of the entire coding region
qCarrier Plus Quantitative Genomic Medicine Laboratories, SL Spain	328	300	C Sequence analysis of the entire coding region
Cancer Panel PreventionGenetics, part of Exact Sciences United States	122	117	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Hereditary Breast and Ovarian Cancer via the RAD50 Gene PreventionGenetics, part of Exact Sciences United States	2	1	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
RAD50 MLPA Institute for Human Genetics University Medical Center Freiburg Germany	1	1	D Deletion/duplication analysis
VistaSeq Comprehensive Cancer Panel Molecular Diagnostic Laboratory LabCorp United States	47	59	D Deletion/duplication analysis C Sequence analysis of the entire coding region
RAD50 Sequence Analysis (Familial Mutation/Variant Analysis) Baylor Genetics United States	1	1	T Targeted variant analysis
RAD50 Gene Sequencing by Massively Parallel Sequencing (BCM-NGSSM) Baylor Genetics United States	1	1	E Sequence analysis of select exons
RAD50 Sequence Analysis (Prenatal Sequence Analysis) Baylor Genetics United States	1	1	E Sequence analysis of select exons
Microcephaly Panel CNH Molecular Diagnostics Laboratory Childrens National Hospital United States	67	48	C Sequence analysis of the entire coding region
Fanconi Anemia NGS Panel Genomic Diagnostic Laboratory, Division of Genomic Diagnostics Children's Hospital of Philadelphia United States	8	25	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Comprehensive Primary Immunodeficiency NGS Panel Fulgent Genetics United States	1048	472	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Breast and Ovarian Cancer Focus Panel Fulgent Genetics United States	50	21	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Breast and Ovarian Cancer Comprehensive Panel Fulgent Genetics United States	58	24	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Full Focus Cancer Panel Fulgent Genetics United States	82	30	D Deletion/duplication analysis C Sequence analysis of the entire coding region
NIJMEGEN BREAKAGE SYNDROME Laboratorio de Genetica Clinica SL Spain	1	1	E Sequence analysis of select exons C Sequence analysis of the entire coding region T Targeted variant analysis

<< First < Prev

Page 2 of 3

Results: 21 to 40 of 53

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.